2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Nasopharyngeal Carcinoma
11
Leukemia, Myeloid, Acute
4
Carcinoma, Non-Small-Cell Lung
4
Nasopharyngeal Neoplasms
3
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Myelodysplastic Syndromes
2
Turcot syndrome
1
Tongue Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Patient Outcome Assessment
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma
1
Locally Advanced Malignant Neoplasm
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hypopharyngeal Neoplasms
1
Interventions
Fulvestrant
3
palbociclib
2
Letrozole
2
Anastrozole
2
venetoclax
1
pyrotinib
1
pertuzumab
1
penpulimab
1
dalpiciclib
1
anlotinib
1
Tretinoin
1
Trastuzumab
1
Ropivacaine
1
Radiosurgery
1
Propofol
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Ondansetron
1
Morphine
1
Induction Chemotherapy
1
Etoricoxib
1
Docetaxel
1
Diagnostic Imaging
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasm Female
×
Induction Chemotherapy
×
Clear all
NCT03011060
2017-01-10
NACVCAC
The First Hospital of Jilin University
Phase 3
Unknown
1,588 enrolled